|
⚲
|
| Keyboard |
| Brusegard David
✚
|
|
|---|---|
| CIK # | 0001516920 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001516920] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Generex Biotechnology Corp | |
| Brusegard David |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Generex Biotechnology Corp GNBT
Common Stock
|
2016-02-16 | Option exercise | 1,667,671 | $0.00 | |
|
Generex Biotechnology Corp GNBT
Common Stock Purchase Option · derivative
|
2016-02-16 | Option exercise | 1,667,671 | $0.00 | |
|
Generex Biotechnology Corp GNBT
Common Stock Purchase Option · derivative
|
2016-02-09 | Option exercise | 845,492 | $0.00 | |
|
Generex Biotechnology Corp GNBT
Common Stock Purchase Option · derivative
|
2016-02-09 | Option exercise | 1,667,671 | $0.00 | |
|
Generex Biotechnology Corp GNBT
Common Stock Purchase Option · derivative
|
2016-02-09 | Option exercise | 595,239 | $0.00 | |
|
Generex Biotechnology Corp GNBT
Common Stock Purchase Option · derivative
|
2016-02-09 | Option exercise | 1,928,925 | $0.00 | |
|
Generex Biotechnology Corp GNBT
Common Stock Purchase Option · derivative
|
2016-02-09 | Option exercise | 546,448 | $0.00 | |
|
Generex Biotechnology Corp GNBT
Common Stock
|
2016-02-09 | Option exercise | 5,583,775 | $0.00 | |
|
Generex Biotechnology Corp GNBT
Common Stock Purchase Option (right to buy) · derivative
|
2013-10-31 | Grant | 845,492 | $0.00 | |
|
Generex Biotechnology Corp GNBT
Common Stock Purchase Option (Right to Buy) · derivative
|
2013-06-06 | Grant | 595,239 | $0.00 | |
|
Generex Biotechnology Corp GNBT
Common Stock Purchase Option (right to buy) · derivative
|
2013-04-01 | Grant | 1,928,925 | $0.00 | |
|
Generex Biotechnology Corp GNBT
Common Stock Purchase Option (right to buy) · derivative
|
2012-06-20 | Grant | 546,448 | $0.00 |